Biosimulation Market Accelerating Drug Development Through Advanced Modeling and Predictive Technologies

AI Briefing

• – The global biosimulation market is driven by the need for cost-effective drug development and rising complexity in clinical trials.
• – Advancements in computational modeling technologies are accelerating the market growth.
• – The market was valued at USD 5.5 billion in 2022 and is expected to reach USD 13.4 billion by 2027.